Acumen Pharmaceuticals Total Risk Alpha
| ABOS Stock | | | USD 3.43 0.16 4.89% |
The Total Risk Alpha lookup presents technical context for Acumen Pharmaceuticals and related instruments. Some instruments may have limited coverage due to data differences;
Equity Screeners lists screening tools. Acumen Pharmaceuticals has a market cap of 198.08 M, ROE of -85.93%.
Trending Equities can help frame allocation decisions. This reflects a position in Acumen Pharmaceuticals within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in employment.
Ready to invest in Acumen Stock? Our
How to Invest in Acumen Pharmaceuticals guide walks you through the process.
Acumen Pharmaceuticals has current Total Risk Alpha of 1.25. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | 1.25 | |
| ER[a] | = | Expected return on investing in Acumen Pharmaceuticals |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Acumen Pharmaceuticals |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Acumen Pharmaceuticals Total Risk Alpha Peers Comparison
Acumen Total Risk Alpha Relative To Other Indicators
Acumen Pharmaceuticals maintains a
second standing in total risk alpha relative to competitors. It is currently under evaluation in maximum drawdown relative to competitors yielding
31.19 of Maximum Drawdown per Total Risk Alpha. For Acumen Pharmaceuticals, Maximum Drawdown stands at
31.19 times Total Risk Alpha
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.